Jacobs A-M F, Nicol S M, Hislop R G, Jaffray E G, Hay R T, Fuller-Pace F V
Cancer Biology Group, Division of Pathology and Neuroscience, University of Dundee, Ninewells Hospital and Medical School, Ninewells Drive, Dundee, Tayside, UK.
Oncogene. 2007 Aug 30;26(40):5866-76. doi: 10.1038/sj.onc.1210387. Epub 2007 Mar 19.
The nuclear protein p68 (also known as Ddx5) is a prototypic member of the 'DEAD box' family of RNA helicases, which has been shown to be abnormally expressed and modified in colorectal tumors and to function as an important transcriptional regulator. Here, we show that p68 is modified in vivo on a single site (K53) by the small ubiquitin-like modifier-2 (SUMO-2). We demonstrate that the SUMO E3 ligase PIAS1 interacts with p68 and enhances its SUMO modification in vivo. To determine the functional consequences of SUMO modification, we compared the transcriptional activity of p68 and a K53R mutant that could not be SUMO-modified. Our data show that SUMO modification enhances p68 transcriptional repression activity and inhibits the ability of p68 to function as a coactivator of p53. These findings may be explained by the ability of wild type, but not K53R p68, to alter the modification state of chromatin by recruitment of histone deacetylase 1 (HDAC1).
核蛋白p68(也称为Ddx5)是RNA解旋酶“DEAD盒”家族的典型成员,已证明其在结直肠肿瘤中异常表达和修饰,并作为重要的转录调节因子发挥作用。在此,我们表明p68在体内通过小泛素样修饰物2(SUMO-2)在单个位点(K53)上发生修饰。我们证明SUMO E3连接酶PIAS1与p68相互作用并增强其在体内的SUMO修饰。为了确定SUMO修饰的功能后果,我们比较了p68和不能进行SUMO修饰的K53R突变体的转录活性。我们的数据表明,SUMO修饰增强了p68的转录抑制活性,并抑制了p68作为p53共激活因子的功能。这些发现可能是由于野生型而非K53R p68通过募集组蛋白去乙酰化酶1(HDAC1)改变染色质修饰状态的能力所致。